C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2001
11/22/2001	WO2001088159A2 Cd28 synthebody for the modulation of immune responses
11/22/2001	WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	WO2001088140A1 Polypeptide involved in cell adhesion and phagocytosis and its use in treatment
11/22/2001	WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	WO2001088132A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
11/22/2001	WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001	WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001	WO2001088100A1 Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof
11/22/2001	WO2001088085A2 Novel bee venom polypeptides and methods of use thereof
11/22/2001	WO2001087983A1 Diagnostic method for screening complement regulatory protein levels to predict spontaneous abortion
11/22/2001	WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087980A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087937A2 G-protein coupled receptors
11/22/2001	WO2001087934A2 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087922A2 Derivatisation of proteins in aqueous solution
11/22/2001	WO2001087340A1 Remedies for cancer
11/22/2001	WO2001087339A1 Antithrombotic agents
11/22/2001	WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	WO2001087337A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	WO2001087336A1 Cancer treatments by using a combination of an antibody against her2 and interleukin -2
11/22/2001	WO2001087335A2 Method for selectively inhibiting ghrelin action
11/22/2001	WO2001087334A1 Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumors agents
11/22/2001	WO2001087331A1 Pharmaceuticals for depressing autoimmune disorders by idiotype binding fragments of anti-idiotypic antibodies
11/22/2001	WO2001087310A1 Process for reducing antibody response against xenografts
11/22/2001	WO2001087302A1 Detection of antibodies to squalene in serum
11/22/2001	WO2001087233A2 Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof
11/22/2001	WO2001087058A1 Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof
11/22/2001	WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001	WO2001036977A3 Identification of disease markers involving mass-based-separation
11/22/2001	WO2001036639A3 Bt toxin receptors from lepidopteran insects and methods of use
11/22/2001	WO2001036476A3 Ing2, an iaps associated cell cycle protein, compositions and methods of use
11/22/2001	WO2001036463A3 Genes specifically expressed in human dendritic cells
11/22/2001	WO2001035995A3 Tr3-specific binding agents and methods for their use
11/22/2001	WO2001034805A3 Human vanilloid receptor gene
11/22/2001	WO2001030969A8 Stanniocalcin proteins and nucleic acids and methods based thereon
11/22/2001	WO2001027269A3 Vip54 protein and related materials
11/22/2001	WO2001027268A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
11/22/2001	WO2001027146A3 Chemokine receptor
11/22/2001	WO2001018169A3 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases
11/22/2001	WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001	WO2000055633A9 Methods of screening for colorectal cancer modulators
11/22/2001	WO2000047713A9 Genes encoding the 5h7 antibody and methods for conferring programmed cell death properties to cells
11/22/2001	US20010044524 Method for preparing dual virally inactivated immune globulin for intravenous administration
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001	US20010044397 Bleaching enzymes and detergent compositions comprising them
11/22/2001	US20010044122 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
11/22/2001	US20010044118 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD
11/22/2001	US20010044116 Particulate support bound to at least 2 signal-generating moieties each of which generates, in situ, a signal different from that generated by the other(s); each signal can be varied over a series of gradations
11/22/2001	US20010043928 Serum preparations for inhibiting retroviruses and tumor growth
11/22/2001	CA2411369A1 Antithrombotic agents
11/22/2001	CA2409746A1 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	CA2409703A1 Novel differentiation inducing process of embryonic stem cell to ectodermal cell and its use
11/22/2001	CA2409652A1 Aromatase inhibitors and monoclonal anti-her2 antibodies as antitumors agents
11/22/2001	CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001	CA2409361A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001	CA2409148A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001	CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001	CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001	CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001	CA2408974A1 Cancer treatments by using a combination of an antibody against her2 and interleukin -2
11/22/2001	CA2408835A1 Compositions and methods for epitope mapping
11/22/2001	CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001	CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001	CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001	CA2408134A1 G-protein coupled receptors
11/22/2001	CA2398979A1 Novel bee venom polypeptides and methods of use thereof
11/21/2001	EP1156117A2 Methods for isolating modulators of carotenoid biosynthesis enzymes
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156103A2 Oplophorus luciferase
11/21/2001	EP1156064A2 Cat-mouse chimeric antibody directed to feline diseases and corresponding heterohydridoma
11/21/2001	EP1156063A1 Antibodies to the granulocyte colony stimulating factor receptor
11/21/2001	EP1156062A1 Immunomodulatory human MHC class II antigen-binding peptides/proteins
11/21/2001	EP1156060A1 Human peptides/proteins causing or leading to the killing of cells including lymphoid tumor cells
11/21/2001	EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001	EP1155323A1 Detection method for microthrix parvicella
11/21/2001	EP1155038A1 Epitopes or mimotopes derived from the c-epsilon-3 or c-epsilon-4 domains of ige, antagonists thereof, and their therapeutic uses
11/21/2001	EP1155037A1 Epitopes or mimotopes derived from the c-epsilon-2 domain of ige, antagonists therof, and their therapeutic uses
11/21/2001	EP1155036A1 Mite protein
11/21/2001	EP1155035A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
11/21/2001	EP1154797A2 Multi-mutant diphtheria toxin vaccines
11/21/2001	EP1154786A2 Methods and compositions for altering mucus secretion
11/21/2001	EP1154691A1 Targeted transscleral controlled release drug delivery to the retina and choroid
11/21/2001	EP0773962B1 Antibodies which activate an erythropoietin receptor
11/21/2001	EP0767676B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions
11/21/2001	EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors
11/21/2001	EP0742902B1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/21/2001	EP0711305B1 Protegrins
11/21/2001	EP0644768B1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
11/21/2001	CN1323347A Means and methods for modulating stomata characteristica in plants
11/21/2001	CN1323346A TPL-2/COT kinase and methods of use
11/21/2001	CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001	CN1323223A Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
11/21/2001	CN1323221A Immunogenic beta-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an N-acryloylated polysaccharide

1 ... 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 ... 1494